|
FOR RELEASE ON |
25 APRIL 2022 |
IP Group plc - DBSP awards; Director/PDMR shareholding
IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which develops world-changing science and technology businesses across life sciences, technology and cleantech, announces the following in connection with its employee share schemes.
Deferred Bonus Share Plan ("DBSP") Awards
IP Group has granted nil-cost options over ordinary shares of two pence each ("Shares") to the executive directors and persons discharging managerial responsibilities ("PDMRs") under the Group's DBSP on 21 April 2022. The grants reflect the deferral of fifty per cent of each person's award above £25,000 under the Group's Annual Incentive Scheme ("AIS") in respect of the Group's performance for the financial year ended 31 December 2021. The following table sets out details of the awards made to the Executive Directors and PDMRs:
|
Name of Director/PDMR |
Structure of award |
Number of options granted |
Total number of options currently held |
|
Greg Smith |
Nil-Cost Option |
176,200 |
298,403 |
|
David Baynes |
Nil-Cost Option |
150,902 |
269,013 |
|
Sam Williams |
Nil-Cost Option |
82,364 |
153,086 |
|
Mark Reilly |
Nil-Cost Option |
94,736 |
160,210 |
|
Angela Leach |
Nil-Cost Option |
58,224 |
102,758 |
|
Christopher Glasson |
Nil-Cost Option |
41,088 |
64,980 |
|
Lisa Patel |
Nil-Cost Option |
3,680 |
5,970 |
|
Liz Vaughan-Adams |
Nil-Cost Option |
38,272 |
52,664 |
|
Moray Wright |
Nil-Cost Option |
84,876 |
88,260 |
|
Dan Xie |
Nil-Cost Option |
29,790 |
44,874 |
|
Anthony York |
Nil-Cost Option |
33,498 |
33,498 |
|
Total |
|
793,630 |
1,273,716 |
In addition to the above, awards over a total of 1,272,544 Shares were made to certain other of the Group's employees. As at the date of this announcement, a total of 3,377,871 nil-cost options over Shares remain outstanding under the IP Group DBSP.
No consideration was paid for the grant of the awards and no consideration is due on the maturity of the option period. Fifty per cent of the options will normally be automatically exercised on 31 March 2023 and fifty per cent on 31 March 2024, with each such automatic exercise generally subject to continued employment.
Shares in issue
At the date of this announcement, the Company continues to have 1,063,033,287 Shares in issue and 28,938,473 Shares held in treasury.
The following information is being disclosed pursuant to the requirements of MAR.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
DBSP awards
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||||||||||||||||||||||||||||||||
|
a) |
Name |
Greg Smith Lisa Patel Liz Vaughan-Adams Moray Wright Dan Xie Anthony York |
||||||||||||||||||||||||||||||||||||
|
2 |
Reason for the notification |
|||||||||||||||||||||||||||||||||||||
|
a) |
Position/status |
Director Chief Executive Officer PDMR Finance Director PDMR Partner, Employee Executive PDMR Director of Communications PDMR CEO Parkwalk PDMR Partner, Employee Executive PDMR Group People Director
|
||||||||||||||||||||||||||||||||||||
|
b) |
Initial notification /Amendment |
Initial Notification |
||||||||||||||||||||||||||||||||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||||||||||||||||||||||||||||||
|
a) |
Name |
IP Group plc |
||||||||||||||||||||||||||||||||||||
|
b) |
Legal Entity Identifier |
213800HG22UM138WFG43 |
||||||||||||||||||||||||||||||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||||||||||||||||||||||||||||||
|
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary Shares of 2p each in IP Group plc
|
||||||||||||||||||||||||||||||||||||
|
b) |
Nature of the transaction |
Grant of nil-cost options under the IP Group plc DBSP |
||||||||||||||||||||||||||||||||||||
|
c) |
Currency |
GBP |
||||||||||||||||||||||||||||||||||||
|
d) |
Price(s) and volume(s) |
|
||||||||||||||||||||||||||||||||||||
|
e) |
Aggregated information -Aggregated volume - Price - Aggregated total |
Aggregated number of options granted under the DBSP to Directors and PDMRs on 21 April 2022: 793,630 Price: £ nil |
||||||||||||||||||||||||||||||||||||
|
f) |
Date of the transaction |
21 April 2022 |
||||||||||||||||||||||||||||||||||||
|
g) |
Place of the transaction |
Outside a trading venue
|
||||||||||||||||||||||||||||||||||||
For more information, please contact:
|
IP Group plc |
|
|
|
|
|
Charlotte Street Partners |
|
|
David Gaffney |
+44 (0) 7854 609998 |
|
Andrew Wilson |
+44 (0) 7810 636995 |
Notes for editors
About IP Group
IP Group develops world-changing science and technology businesses across life sciences, technology and cleantech. The Group has a strong track record of success, having been the founder investor in a number of high-profile companies including Oxford Nanopore Technologies plc, and has one of the most exciting portfolios of high-growth businesses in Europe. The Group also owns Parkwalk, the UK's largest growth EIS fund manager which backs world-changing technologies emerging from the UK's leading universities and research institutions. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.
For more information, please visit our website at www.ipgroupplc.com.
ENDS
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
